Compare ECOR & CLST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ECOR | CLST |
|---|---|---|
| Founded | 2005 | 1922 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.0M | 70.0M |
| IPO Year | 2018 | 2021 |
| Metric | ECOR | CLST |
|---|---|---|
| Price | $9.37 | $17.26 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | ★ 72.2K | 1.8K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 171.79 |
| EPS | N/A | ★ 0.15 |
| Revenue | ★ $32,032,000.00 | N/A |
| Revenue This Year | $33.60 | N/A |
| Revenue Next Year | $30.40 | N/A |
| P/E Ratio | ★ N/A | $114.33 |
| Revenue Growth | ★ 27.20 | N/A |
| 52 Week Low | $4.41 | $12.51 |
| 52 Week High | $10.50 | $18.16 |
| Indicator | ECOR | CLST |
|---|---|---|
| Relative Strength Index (RSI) | 72.06 | 56.29 |
| Support Level | $8.55 | $16.24 |
| Resistance Level | $9.53 | $17.27 |
| Average True Range (ATR) | 0.78 | 0.31 |
| MACD | 0.42 | 0.01 |
| Stochastic Oscillator | 89.01 | 68.21 |
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It operates in one reportable segment, which generates income principally from interest on loans and investment securities, as well as from fees charged in connection with various loan and deposit services.